Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-02

Clinical Trial Update: A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome. [Phase 1]

View source ↗

Summary

A multicenter Phase 1 randomized study is evaluating the safety of the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment for plaque psoriasis with blood st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment (Qinteng Huoxue Runji ointment)

Snippet

Sponsor: Beijing Hospital of Traditional Chinese Medicine | Conditions: Plaque Psoriasis | Phase 1 | Status: NOT_YET_RECRUITING